STOCK TITAN

Kamada HR VP receives options covering 100K shares

The VP Human Resources’ awards are held by a trustee and vest in four equal installments, with 25% vesting on each grant anniversary.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

KAMADA LTD VP Human Resources Reshef Liron reported grants on August 27, 2026, of employee stock options covering 40,000 and 60,000 ordinary shares. The options are held by a trustee under the company’s 2011 Share Award Plan. Their reported USD exercise prices are $5.12 and $7.44 per share, adjusted in connection with a special cash dividend distribution declared August 17, 2026, with a record date of August 27, 2026. Each award vests in four equal installments, with 25% vesting on each anniversary of its grant date.

Positive

  • None.

Negative

  • None.
Insider Reshef Liron
Role VP Human Resources
Type Security Shares Price Value
Grant/Award Employee Stock Option (right to buy) F1, F4, F2, F3 40,000 $0.00 $0.00
Grant/Award Employee Stock Option (right to buy) F1, F5, F2, F3 60,000 $0.00 $0.00
Holdings After Transaction: Employee Stock Option (right to buy) — 100,000 contracts (Indirect, Held by trustee)
Footnotes (5)
  1. F1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.
  2. F2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
  3. F3. Held by trustee under the Company's 2011 Share Award Plan.
  4. F4. This option was previously reported as covering 40,000 ordinary shares at an exercise price of $5.29. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
  5. F5. This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
Option award underlying shares 40,000 ordinary shares Award reported August 27, 2026
Option award underlying shares 60,000 ordinary shares Award reported August 27, 2026
Exercise price $5.12 per share Reported USD presentation; adjusted in connection with the special cash dividend distribution
Exercise price $7.44 per share Reported USD presentation; adjusted in connection with the special cash dividend distribution
Vesting installments 4 equal installments Options vest on anniversaries of the grant date
Vesting per installment 25% Vests on each of the four grant-date anniversaries
exercise prices financial
"The exercise prices of all options reported"
vest in four equal installments financial
"Options vest in four equal installments"
special cash dividend distribution financial
"adjusted in connection with a special cash dividend distribution"
2011 Share Award Plan financial
"Held by trustee under the Company's 2011 Share Award Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares do KMDA’s reported option awards cover?

Reshef Liron, KAMADA LTD’s VP Human Resources, reported options covering 40,000 and 60,000 ordinary shares on August 27, 2026. The options are held by a trustee under the company’s 2011 Share Award Plan.

What are the exercise prices and vesting terms for KMDA’s option awards?

The reported USD exercise prices are $5.12 and $7.44 per share. Each award vests in four equal installments, with 25% vesting on each of the four anniversaries of its grant date.

Why were KMDA’s option exercise prices adjusted?

The exercise prices were adjusted in connection with a special cash dividend distribution declared by KAMADA LTD’s board on August 17, 2026, with a record date of August 27, 2026. The options had previously been reported at exercise prices of $5.29 and $7.61.

Were the KMDA option awards reported under a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported for these option awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Reshef Liron

(Last)(First)(Middle)
2 HOLTZMAN ST.

(Street)
REHOVOT

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
VP Human Resources
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$5.12(1)(4)08/27/2026A40,000 (2) (2)Ordinary Shares40,000$0.0040,000IHeld by trustee(3)
Employee Stock Option (right to buy)$7.44(1)(5)08/27/2026A60,000 (2) (2)Ordinary Shares60,000$0.0060,000IHeld by trustee(3)
Explanation of Responses:
1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.
2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
3. Held by trustee under the Company's 2011 Share Award Plan.
4. This option was previously reported as covering 40,000 ordinary shares at an exercise price of $5.29. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
5. This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
/s/ Liron Reshef09/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading